AVLSA
IMA

Atlas Venture Life Science Advisors’s ImageneBio Inc IMA Stock Holding History

Atlas Venture Life Science Advisors’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-377,814
Closed -$3.08M – 9
2025
Q3 		$3.08M Sell
377,814
-40,368
-10% -$535K 0.41% 9
2025
Q2 		$6.72M Hold
418,182
– – 1.02% 9
2025
Q1 		$6.42M Hold
418,182
– – 1.23% 9
2024
Q4 		$8.23M Hold
418,182
– – 1% 9
2024
Q3 		$8.68M Hold
418,182
– – 0.8% 11
2024
Q2 		$8.28M Hold
418,182
– – 0.87% 11
2024
Q1 		$7.13M Hold
418,182
– – 0.66% 12
2023
Q4 		$9.89M Hold
418,182
– – 1.18% 11
2023
Q3 		$21.7M Hold
418,182
– – 3.37% 10
2023
Q2 		$32.9M Hold
418,182
– – 4.1% 10
2023
Q1 		$17.3M Hold
418,182
– – 2.34% 11
2022
Q4 		$13.3M Hold
418,182
– – 1.61% 11
2022
Q3 		$17.8M Hold
418,182
– – 1.97% 10
2022
Q2 		$22.2M Hold
418,182
– – 3.72% 7
2022
Q1 		$30.6M Hold
418,182
– – 3.87% 9
2021
Q4 		$62.9M Buy
+418,182
New +$67.8M 5.78% 5

Other funds holding IMA

BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Atlas Venture Life Science Advisors's IMA Position: Q4 2025 in Review

Atlas Venture Life Science Advisors sold out of ImageneBio Inc (IMA) in Q4 2025, closing a stake of 377,814 shares — an estimated $3.08M sold.

Atlas Venture Life Science Advisors first reported a position in IMA in Q4 2021 and held it in 16 quarters. The position peaked at $62.9M in Q4 2021. 41 funds tracked by Wall St. Rank hold IMA as of Q4 2025.

  • Atlas Venture Life Science Advisors reported no remaining ImageneBio Inc position as of Q4 2025 after selling out during the quarter.
  • Atlas Venture Life Science Advisors sold 377,814 ImageneBio Inc shares in Q4 2025, an estimated $3.08M.
  • Atlas Venture Life Science Advisors first reported a position in ImageneBio Inc in Q4 2021 and held it in 16 quarters.
  • Atlas Venture Life Science Advisors's ImageneBio Inc position peaked at $62.9M in Q4 2021.
  • 41 funds tracked by Wall St. Rank held ImageneBio Inc as of Q4 2025.

Based on Atlas Venture Life Science Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.